Evonik Jayhawk and Nexam Chemical form Joint Marketing Program; Focus on Polyimide Solutions

Galena (KS, USA) September 1, 2015

Evonik Jayhawk Fine Chemicals Corporation and Nexam Chemical AB have begun a joint-marketing program, whereby Evonik's JAYHAWK dianhydrides and Nexam Chemical's NEXIMID® crosslinkers will be offered in a coordinated effort to the growing polyimide market sector. Evonik and Nexam Chemical will collaborate on modifying and improving polyimide processing, while offering physical and mechanical property enhancements. Customers will benefit from consultation in product selection, pairing and optimal dosing to achieve desired properties of their polyimide coatings, films, fibers, foams and resins.

Said Dr. Jeff Dimmit, VP Technology for Evonik Jayhawk, "Our first collaboration was the "Empowering Polyimides" webinar, narrated by Dr. Carlos Solano, Product Manager for Nexam Chemical. The participation and lively Q&A period frankly overwhelmed us. This positive proof that the industry is thirsty for knowledge on how to use our products together, has led us to move into a market collaboration."

Downloads

Contact

Borys Schafran

Specialized/Local press contact

  • About Performance Materials

    The Performance Materials Segment is managed by Evonik Performance Materials GmbH. The segment focuses its global activities on developing and manufacturing polymer materials and intermediates, especially for use in agriculture and in the rubber and plastics industry. In 2014, the segment’s roughly 4,400 employees generated sales of €3.83 billion.

  • About Evonik

    Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. In its business activities, which are spread across three segments—Nutrition & Care, Resource Efficiency, and Performance Materials—Evonik’s greatest resources are its innovative prowess and integrated technology platforms. In 2014, over 33,000 employees generated sales of around €12.9 billion and an operating profit (adjusted EBITDA) of about €1.9 billion.

  • Disclaimer

    In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.